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Background: A Tei index is known to reﬂect overall cardiac performance including
systolic and diastolic function in a variety of heart disease. We investigated the
relationship between preoperative Tei index and postoperative left ventricular (LV)
mass regression and survival after aortic valve replacement (AVR) for aortic valve
stenosis (AS).
Methods: One hundred ﬁfty-four patients with AS were classiﬁed into a group with
abnormal (Abn) LV function (n = 47, 0.45≤Tei index) and a group with normal (Nor)LV dysfunction;
Tei index
LV function (n = 107, Tei index < 0.45). The pre- and postoperative echocardiographic
variables including LV dimension, LV wall thickness, and LV mass regression as well
as 6-year survival were compared between the two groups.
igniﬁcant difference in both absolute and relative LV massResults: There was a s
index (LVMI) regression (P = 0.004 and 0.0007). Multiple linear regression analysis
revealed that the preoperative LVMI, Tei index, and follow-up period were indepen-
dent predictors of LVMI regression after AVR. Thirteen patients died (valve-related
Abbreviations: AS, aortic stenosis; AVA, aortic valve area; AVR, aortic valve replacement; BSA, body surface area; CABG, coronary
artery bypass grafting; EOA, effective oriﬁce area; EOAI, indexed effective oriﬁce area; IVS, interventricular septal thickness; LV,
left ventricular; LVEF, left ventricular ejection fraction; LVDD, left ventricular end-diastolic diameter; LVM, left ventricular mass;
LVMI, left ventricular mass index; NYHA, New York Heart Association; PG, pressure gradient; PPM, prosthesis-patient mismatch; PW,
posterior wall thickness.
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death in 5). Although the overall survival rate in the Nor-LV group (92.8%) was signiﬁ-
cantly better than that in the Abn-LV group (71.6%), there was no signiﬁcant difference
in survival free from valve-related death.
Conclusions: Preoperative Tei index can be one of the signiﬁcant predictors of LVMI
regression and overall survival after AVR.
e of
I
R
c
e
(
b
a
h
c
d
P
v
r
t
e
L
e
s
I
t
T
s
P
F
u
t
m
g
p
i
r
b
a
t
o
F
o
n
p
p
t
o
l
t
t
i
o
t
T
i
i
w
T
b
A
f
d
(
i
e
(
a
w
g
S
T
g
c
n
w
e
f
t
e
w
a
m
s
i
a
interrupted, noneverting pledgets vertical mattress
sutures.© 2009 Japanese Colleg
reserved.
ntroduction
eduction of the left ventricular mass (LVM) with
onsequent improvement in cardiac function is an
ssential objective of aortic valve replacement
AVR) in patients with aortic stenosis (AS). However,
ecause of small valve annulus often seen in AS,
n inappropriately smaller size of prosthetic valves
ave to be implanted in some cases. Since the con-
ept of prosthesis-patient mismatch (PPM) was ﬁrst
escribed by Rahimtoola in 1978, the impact of the
PM on postoperative LV mass regression or sur-
ival has been intensively investigated, however, it
emains controversial [1].
Recently, Ruel and coworkers showed coexis-
ence of the LV systolic dysfunction with low
jection fraction ampliﬁed the risk of the PPM on
VM regression and survival [2]. Apart from the LV
jection fraction, the Tei index is a combined mea-
ure of both systolic and diastolic LV function [3].
n the present study, we focused on the inﬂuence of
he preoperative LV performance estimated by the
ei index on LVM regression and survival at the late
tage after AVR.
atients and methods
rom January 2000 to December 2006, 343 patients
nderwent AVR, and we selected 154 consecu-
ive patients with aortic stenosis that received a
echanical or bioprosthetic valve. Patients under-
oing other concomitant surgical procedures were
ermitted to enter the study. Exclusion criteria
ncluded severe aortic regurgitation, severe mitral
egurgitation, mitral stenosis, coronary artery
ypass grafting (CABG) for unstable angina, and
cute or healed myocardial infarction. Periopera-
ive data were obtained by retrospective review
f hospital records and echocardiographic reports.
ollow-up information was obtained directly in
ur hospital and through comprehensive question-
aires and by telephone interview with surviving
atients, family members, or the patient’s personal
hysician. The study was approved by our institu-
ion’s review board (IRB) and informed consent was
btained from all patients. The Tei index was calcu-
D
P
sCardiology. Published by Elsevier Ireland Ltd. All rights
ated as (ICT + IRT)/ET (ICT: isovolemic contraction
ime, IRT: isovolemic relaxation time, and ET: ejec-
ion time). The normal Tei index is 0.39± 0.05;
t is assumed that a value of >0.45 is indicative
f LV dysfunction. Ono and coworkers reported
hat the patients with various heart disease whose
ei index more than 0.45 showed signiﬁcantly
ncreased BNP levels than the patients with Tei
ndex less than 0.45. Based on their conclusion,
e set the cut-off value of Tei index as 0.45 [4].
he patients (n = 154) were divided into two groups
ased on a preoperative Tei index≥ 0.45 (n = 47;
bn-LV group) or <0.45 (n = 107; Nor-LV group)
or comparative analysis. Postoperative echocar-
iography was performed from 7 days to 6 years
mean, 1.98± 1.8 years) following the operation
n all patients, and the preoperative and postop-
rative values of transvalvular pressure gradient
PG), LV systolic and diastolic function, and the
bsolute and relative regression in LVM index (LVMI)
ere compared between the Abn-LV and the Nor-LV
roups.
urgical techniques
he operation was performed by two senior sur-
eons (RS) and (YI). The patients were placed on
ardiopulmonary bypass by aortic and bicaval can-
ulation. After antegrade cold cardioplegia solution
as infused, an oblique aortotomy was made to
xpose the aortic valve. The vent tube was inserted
rom the right superior pulmonary vein. Selec-
ive infusion of cardioplegia solution was repeated
very 30min during cardiac arrest. Prosthesis size
as selected according to the size of the aortic
nnulus; the prosthesis was usually implanted by
eans of multiple, interrupted, everting, mattress
utures reinforced with Teﬂon pledgets placed in an
ntra-annular position or was implanted in a supra-
nnular position using the technique of multiple,oppler echocardiographic measurements
reoperative and postoperative echocardiographic
tudies were performed by experienced echocar-
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diographers using a 2- or 3-MHz transducer and
phased array sector scanner (HDI 5000, ATL Ultra-
sound, Inc., Bothell, WA, USA; Sonos 5500, Phillips
Medical Systems, Andover, MA, USA). The preop-
erative echocardiograms were recorded 0—7 days
before surgery and postoperative echocardiograms
were obtained at least 7 days after the opera-
tion. Standard parasternal, apical, subcostal, and
suprasternal views were obtained. Hemodynamic
variables were calculated using standard formu-
lae. The measurement and signiﬁcance of the Tei
index are described in detail elsewhere [3]. The
transvalvular PG was determined using the modi-
ﬁed Bernoulli equation [5]; aortic valve area (AVA)
was calculated by the continuity equation [5]; and
LVM was calculated by the Devereux formula [6].
LV systolic performance was evaluated by means
of the left ventricular ejection fraction (LVEF) cal-
culated from biplane images using a modiﬁcation
of Simpson’s method. LV diastolic performance was
evaluated by means of the E/A and deceleration
time (DcT). The indexed effective oriﬁce area
(EOAI) for each prosthesis was easily calculated
from the normal reference value of effective oriﬁce
area (EOA) divided by the patient’s body surface
area [6].
Pibarot et al. deﬁned PPM as clinically insignif-
icant if the EOAI > 0.85 cm2/m2, as moderate
if it was >0.65 cm2/m2 but ≤0.85 cm2/m2, and
as severe if it was ≤0.65 cm2/m2 [7]. In the
present study, PPM was also deﬁned as an
EOAI≤ 0.85 cm2/m2, based on the recommendation
of Pibalot et al.
Statistical analysis
The data were statistically analyzed using JMP
6.0.3 software (SAS, Inc., Chicago, IL, USA). The
continuous variables were expressed as mean val-
ues± standard deviation (S.D.). The normality of
the distributions in the two groups was tested by
means of the Shapiro—Wilk test. A Student’s t-test
or Wilcoxon test for continuous variables, and a
chi-square test or Fisher’s exact test for discrete
variables were used, as appropriate. The relation-
ship between the preoperative peak PG, mean PG,
EOAI, the preoperative LVMI, follow-up period and
the absolute LVMI regression were evaluated by
means of simple linear regression analysis in order
to calculate r (Pearson’s correlation coefﬁcient).
The variables with a P value <0.10 in the univariate
regression analysis were entered into a multiple lin-
ear regression analysis to identify the independent
predictors of absolute LVMI regression. A P value
<0.05 was considered signiﬁcant.
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esults
reoperative data
able 1 shows patients’ preoperative and opera-
ive characteristics classiﬁed into an Abn-LV group
n = 47, Tei index < 0.45) and a Nor-LV group (n = 107,
ei index < 0.45). The mean age, BSA, AVA, peak
ortic PG, and mean aortic PG were not signif-
cantly different between the two groups. There
ere no signiﬁcant differences in prevalence of
emale gender, hemodialysis, New York Heart Asso-
iation (NYHA) class III or IV, and concomitant
rocedures between the two groups. However, the
bn-LV group had more patients with an LVEF ≤40%
ompared with the Nor-LV group.
mplanted valves
here were 126 mechanical prostheses (81.8%) and
8 bioprostheses (18.2%) implanted. Among the
atients, 80 received a St. Jude Medical Hemody-
amic Plus prosthesis (St. Jude Medical, Inc., St.
aul, MN, USA), 13 received a Sorin Bicarbon Slim-
ine prosthesis (Sorin Biomedica, Saluggia, Italy),
1 received a St. Jude Medical standard prosthe-
is (St. Jude Medical, Inc., St. Paul, MN, USA), 7
eceived a Carbomedics Top Hat prosthesis (Car-
omedics, Inc., Austin, TX, USA), 6 received a St.
ude Medical Regent prosthesis (St. Jude Medical,
nc., St. Paul, MN, USA), 6 received an ON-X pros-
hesis (Medical Carbon Research Institute, Austin,
X, USA) and 3 received an ATS Advanced Perfor-
ance prosthesis (ATS Medical, Inc., Minneapolis,
N, USA). All patients in the bioprosthetic group
eceived Carpentier—Edwards perimount biopros-
hesis (Edwards Lifesciences Corp., Inc., Irvine, CA,
SA). The distribution of patients in regard to pros-
hesis size was 17mm in 16 patients, 19mm in
7 patients, 21mm in 56 patients, 23mm in 19
atients, and 25mm in 3 patients. Concomitant
urgical procedures included CABG in 33, com-
ined valvular disease in 2 and ascending aorta
eplacement in 18. We tried to implant prosthetic
alves as large as possible without an aortic-root
nlargement procedure, and subsequently, only
ne patient underwent Nick’s procedure and was
mplanted with an SJM 17mm HP valve.
perative datahe mean EOAI was not different between the two
roups. There were 22 PPM patients (Abn-LV, 5; Nor-
V, 17) in both groups, and themean EOAI of the PPM
atients was not statistically different between the
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Table 1 Preoperative and operative patient characteristics.
Characteristic Abn-LV Nor-LV P-Value
Number of patients 47 107 —
Age (years), mean± S.D. 72.9± 9.0 70.0± 10.2 0.0954
Sex (female) 55.3% 56.1% 0.9307
BSA (m2), mean± S.D. 1.49± 0.18 1.50± 0.15 0.8360
Aortic valve area (cm2), mean± S.D. 0.58± 0.18 0.59± 0.19 0.7102
Peak aortic gradient (mmHg) mean± S.D. 92.9± 27.0 101.4± 32.3 0.1209
Mean aortic gradient (mmHg), mean± S.D. 54.4± 18.3 58.5± 18.8 0.2114
Valve pathology
AS/ASR 34/13 73/34 0.6095
Bicuspid 34.0% 33.7% 0.9627
Hemodialysis 8.5% 4.7% 0.3498
Atrial ﬁbrillation 6.4% 3.7% 0.4681
LVEF≤ 40% 12.8% 2.8% 0.0152
NYHA class III or IV 28.3% 20.2% 0.2764
AVR only/AVR and concomitant procedure 28/19 70/37 0.4874
Bioprosthesis/mechanical prosthesis 9/38(19.2%) 19/88(17.8%) 0.8366
EOAI (cm2/m2) 0.99± 0.13 0.96± 0.13 0.2050
PPM (EOAI≤ 0.85 cm2/m2) 5(10.6%) 17(15.9%) 0.3913
Aortic cross-clamp time (min) 98.1± 23.3 95.9± 25.8 0.6244
Cardiopulmonary bypass time (min) 139.0± 31.6 133.7± 34.8 0.3736
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New York Heart Association.
wo groups. There was no severe PPM patient in
ither group.
arly mortality
lthough there were no deaths within 30 days after
he operation, 2 patients (1 in Abn-LV group) died
uring the same hospitalization period. The cause
f death was sepsis in one and brain death in one
esulting from ventricular ﬁbrillation induced by a
wan—Ganz catheter during the induction of anes-
hesia. None of these deaths was related to the
rosthetic valve size or LV dysfunction.
ate mortality
he follow-up period ranged from 0.27 to 6.8 years
median, 3.48 years). Eleven patients (Abn-LV, 6;
or-LV, 5) died during the follow-up period. Among
he patients who died, ﬁve deaths (3 in Abn-LV
roup) were valve-related including four sudden
eaths and one cerebral hemorrhage. Among the six
on-valve-related deaths, three patients died from
espiratory failure, one patient died from sepsis,
ne from non-occlusive mesenteric ischemia, and
ne from low output syndrome (LOS). The over-
ll survival rate at 1, 3, and 6 years was 93.5%,
6.7%, and 71.6% in the Abn-LV group, respec-
ively; and 97.2%, 94.8%, and 92.8% in the Nor-LV
T
g
g
d
te area (m2); LVEF, left ventricular ejection fraction (%); NYHA,
roup (P = 0.0307) (Fig. 1). Survival free from valve-
elated death at 1, 3, and 6 years was 97.8%,
0.7%, and 90.7% in the Abn-LV group, respec-
ively; and 99.0%, 99.0%, and 96.9% in the Nor-LV
roup (P = 0.0696) (Fig. 1). There was a signiﬁcant
ifference in overall survival, but no signiﬁcant dif-
erence in survival free from valve-related death
etween the two groups. However, the Nor-LV group
howed a trend toward higher survival free from
alve-related death rate.
rosthetic valve hemodynamics
ollow-up echocardiography was performed at
.52± 1.76 years following the operation in the
bn-LV group and at 2.18± 1.77 years in the Nor-LV
roup (P = 0.0343). There was no signiﬁcant dif-
erence in the postoperative peak and mean PGs
etween the two groups. No structural or functional
bnormalities of the prostheses were found during
he postoperative examination.
eft ventricular morphologic changeshe preoperative and postoperative echocardio-
raphic data are shown in Table 2. In both
roups, LVDd, LVDs, IVS + PW, LVM, and LVMI all
ecreased signiﬁcantly after AVR, where interven-
ricular septal (IVS) and PW are standard measures
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Figure 1 Actuarial survival curve and actuarial freedom from valve-related death. The overall survival rate in the
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vAbn-LV group was signiﬁcantly worse than that in the Nor-L
freedom from valve-related death between two groups (
(in millimeters) of IVS thickness and posterior wall
thickness (PW). There were no signiﬁcant differ-
ences in these parameters between the two groups.
However, there was a signiﬁcant difference in
absolute and relative IVS + PW regression and LVM
regression or LVMI regression between the two
groups.
Left ventricular functional changes
There was a signiﬁcant difference in preopera-
tive LVEF between the two groups, but there was
no difference in postoperative LVEF. There was
no improvement in LVEF after the operation in
either group. Preoperative E/A in the Abn-LV group
was signiﬁcantly lower than that in the Nor-LV
group whereas there was no signiﬁcant difference
between two groups after AVR. The postoperative
Tei index was 0.55± 0.17 in the Abn-LV group and
0.43± 0.15 in the Nor-LV group (P = 0.0007). In the
Nor-LV group, the Tei index signiﬁcantly increased
after AVR (Table 2).
Predictors of left ventricular mass
regression
In univariate regression, the EOAI and preopera-
tive LVEF were not signiﬁcantly correlated with LVMI
regression. However, the absolute LVMI regression
was signiﬁcantly correlated with the preoperative
IVS + PW, peak and mean aortic PG, preoperative
Tei index, preoperative LVMI and follow-up period;
and these variables were entered into a multiple
linear regression analysis. In this analysis, female
sex, preoperative Tei index, preoperative LVMI and
P
T
sup (left). There was no signiﬁcant difference in actuarial
).
ollow-up period were all independent predictors
f LVMI regression after AVR (Table 3).
iscussion
PM, LVM regression, and survival
n the past two decades, numerous studies have
ocused on the relationship among three impor-
ant issues related to AVR for AS, including the
PM, LVM regression, and survival. However, a ret-
ograde fashion in most of these investigations
ncluding patients with different preoperative con-
itions might have contributed, to some extent, to
he varying results and conclusions.
PM and patients’ survival
he impact of PPM on early and long-term patients’
urvival has been intensively investigated and a
ajority of the literature showed their positive
elationship. Blais et al. showed that PPM (severe,
OAI≤ 0.65; moderate, 0.65 < EOAI≤ 0.85) was a
trong and independent predictor of short-term
ortality among patients undergoing AVR [8]. How-
ver, Pibarot et al. studied the impact of PPM
EOAI≤ 0.85) on 7-year survival after AVR and found
o difference between those with and without mis-
atch [7]. In our previous study, the presence of
PM did not signiﬁcantly affect the long-term sur-
ival of patients [9].PM and LVM regression
he relationship between the PPM and LVM regres-
ion also remains controversial. Del Rizzo et al.
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Table 2 Preoperative and postoperative left ventricular morphologic and functional changes.
Parameters Abn-LV Nor-LV P-Value
47 107
Echocardiography follow-up (years) 1.52 ± 1.76 2.18 ± 1.77 0.0343
LVDd (mm) mean± S.D.
Preoperative 46.4 ± 7.12 46.2 ± 6.08 0.8851
Postoperative 44.3 ± 6.83** 42.8 ± 5.46** 0.1493
LVDs (mm) mean± S.D.
Preoperative 30.8 ± 9.28 27.9 ± 7.26 0.0409
Postoperative 28.6 ± 8.30** 26.6 ± 5.67* 0.0879
IVS + PW (mm) mean± S.D.
Preoperative 29.6 ± 5.36 30.6 ± 5.57 0.3009
Postoperative 26.6 ± 4.89** 25.7 ± 4.51** 0.2332
Absolute IVS + PW regression (mm) mean± S.D. 3.00 ± 5.23 5.03 ± 4.52 0.0160
Relative IVS + PW regression (%) mean± S.D. 8.40 ± 18.0 15.3 ± 13.3 0.0090
LVM (g) mean± S.D.
Preoperative 285.1 ± 86.2 301.5 ± 93.0 0.3040
Postoperative 229.0 ± 75.5** 206.3 ± 64.9** 0.0593
Absolute LVM regression (g), mean± S.D. 56.1 ± 78.3 95.8 ± 73.4 0.0029
Relative LVM regression (%), mean± S.D. 16.9 ± 25.3 29.7 ± 18.0 0.0005
LVMI (g/m2), mean± S.D.
Preoperative 191.9 ± 53.6 201.2 ± 57.4 0.3486
Postoperative 152.9 ± 44.5** 136.5 ± 38.1** 0.0210
Absolute LVMI regression (g/m2), mean± S.D. 39.0 ± 53.0 64.7 ± 48.9 0.0040
Relative LVMI regression (%), mean± S.D. 17.3 ± 25.2 29.8 ± 18.2 0.0007
Relative wall thickness, mean± S.D.
Preoperative 0.66 ± 0.18 0.68 ± 0.17 0.5589
Postoperative 0.62 ± 0.16* 0.61 ± 0.14** 0.7897
LVEF (%), mean± S.D.
Preoperative 61.3 ± 16.0 68.2 ± 12.3 0.0040
Postoperative 64.2 ± 12.7 67.1 ± 10.1 0.1250
E/A, mean± S.D.
Preoperative 0.64 ± 0.22 0.82 ± 0.54 0.0331
Postoperative 0.95 ± 0.73 0.92 ± 0.36 0.7428
DcT (ms), mean± S.D.
Preoperative 259.5 ± 92.6 269.6 ± 88.3 0.5423
Postoperative 245.7 ± 78.4 236.1 ± 59.3 0.4920
Tei index, mean± S.D.
Preoperative 0.58 ± 0.13 0.30 ± 0.09 <0.0001
Postoperative 0.55 ± 0.17 0.43 ± 0.15** 0.0007
IVS, interventricular septal thickness (mm); PW, posterior wall thickness (mm); LVM, left ventricular mass (g); LVMI, left ventricular
mass index (%); LVEF, left ventricular ejection fraction (%); DcT, deceleration time.
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a* Postoperative vs. preoperative P < 0.05.
** Postoperative vs. preoperative P < 0.001.
ound a strong, independent relationship between
he EOAI and the extent of LVM regression in
103 patients who underwent AVR with a stent-
ess porcine valve [10]. Tasca et al. showed that in
atients with pure AS, PPM was associated with less
egression of LVM. In their series of studies, a larger
rojected EOAI, female gender, and a higher preop-
rative LVM were independent predictors of greater
d
t
o
mVM regression [11,12]. Contrary to these reports,
anayama et al. found no signiﬁcant relationship
etween PPM and regression of LV hypertrophy,
nd concluded that the most important indepen-
ent predictor of incomplete LVM regression was
he extent of preoperative LVMI rather than the size
f aortic prostheses, the presence of PPM, or the
ean and peak PG [13]. Recently, Imanaka et al.
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Table 3 Independent predictors of absolute LV mass regression in multiple regression analysis.
Predictive variable Univariate analysis Multivariate analysis
P-Value Standardized coefﬁcients (ˇ) S.E. P-Value
Age 0.3460 — — —
Sex (female) 0.0939 0.06387 3.238775 0.2728
IVS + PW <0.0001 — — 0.9274
LVEF 0.5897 — — —
Tei index 0.0026 −0.18645 16.98942 0.0009
Tei index < 0.45 0.0023 — — 0.4212
EOAI 0.9883 — — —
PPM 0.5505 — — —
Preoperative LVMI <0.0001 0.683681 0.052529 <0.0001
RWT 0.0016 — — 0.9679
Preoperative peak PG 0.0147 — — 0.8903
Preoperative mean PG 0.0122 — — 0.6417
0.14
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CFollow-up period 0.0004
Model: r = 0.75, r2 = 56%, P < 0.0001. IVS, interventricular septal
oriﬁce area (cm2/m2); LVM, left ventricular mass (g); LVMI, lef
showed that systolic blood pressure following AVR
was the single variable that signiﬁcantly inﬂuenced
regression of LV mass [14]. In our previous study,
moderate PPM does not appear to alter LVMI regres-
sion, NYHA class, or intermediate-term outcome in
AS patients undergoing AVR with mechanical pros-
theses [9].
LVM regression and patients’ survival
Mehta et al. showed that increased LVMI was asso-
ciated with increased adverse in-hospital clinical
outcome in patients undergoing AVR [15]. Kratz et
al. reported that late deaths after AVR are often
caused by sudden cardiac arrest, arrhythmias, or
congestive heart failure and these late events may
be caused or inﬂuenced by LV hypertrophy [16]. In
our present study, although two in-hospital deaths
were not related to the PPM, it is noteworthy
that three out of 4 sudden deaths occurred in the
patients with increased LVM in the intermediate
term. These reports suggest a positive relationship
between LVM regression and patients’ survival.
These mixed results, especially related to the
PPM, may suggest that the postoperative LVM
regression and survival of such critically ill patients
are multi-factorial and the PPM alone is not sufﬁ-
cient as their deﬁnitive predictor.
Tei index, LVM regression, and survivalIt is noteworthy that signiﬁcant differences were
detected in absolute and relative LVMI regressions
and in the frequency of postoperative increase of
LVM between the two groups without signiﬁcant dif-
ference in the frequency of the PPM. In addition,
T
a
s
A9999 1.594038 0.0084
ness (mm); PW, posterior wall thickness (mm); EOA, effective
tricular mass index (g/m2).
he EOAI had no direct correlation with absolute
nd relative regression of LV wall thickness and
VMI. Intimate correlation between the Tei index
nd LVM regression was further conﬁrmed by mul-
iple linear regression analysis, showing the Tei
ndex was one of the important independent pre-
ictors of greater LVM regression. Because of the
ntimate relationship between the LVM regression
nd patients’ survival mentioned before, it is not
urprising that the overall survival of abnormal Tei
ndex group was signiﬁcantly worse than that of
ormal Tei index group.
tudy limitations
here are several limitations to the present study.
irst, the study was not performed in a prospective
anner. Second, there was a signiﬁcant differ-
nce (P = 0.03) in the interval of echocardiographic
ollow-up. Third, isovolemic contraction and relax-
tion times were not measured independently,
hich made us unable to do further investigations
bout the postoperative changes of the Tei index
n both groups. Fourth, many different types of
echanical valves were implanted. Despite these
imitations, we believe the present study will shed
ome scientiﬁc light on still unexplained issues,
elated to AVR for AS patients.
onclusionhe Tei index can be an independent predictor
lternative to the PPM in postoperative LVM regres-
ion and long-term patients’ survival after AVR for
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